Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...
Drug-induced lung disease cases in France mostly involved ILD, pulmonary edema, and pulmonary fibrosis, largely linked to cancer and CV drugs.
Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback